Skip to content
Subscribe

The future is arriving badly explained.

Essential reads
A minute of perspective

In brief.

Read all editions

Selected · Four signals worth your attention.

  1. A bone marrow chip keeps immune cells in view.

    Researchers combined a lymphoid organoid with a bone marrow chip to track how human antibody-producing cells mature and survive. The laboratory platform could improve studies of vaccines, allergies and autoimmunity; it is not a treatment.

    NIH ·

  2. NASA opens its lunar AI model to researchers.

    NASA and IBM released an open AI model trained on lunar observations. Researchers can adapt it to map craters, identify volcanic features and estimate where polar ice may persist. Those estimates still require scientific validation.

    NASA ·

  3. A Swiss quantum hub opens before its local machine arrives.

    IBM and Lockheed Martin launched a quantum research hub with ETH Zurich. A Nighthawk-powered Quantum System Two is planned for Lugano by year-end; cloud access starts sooner. The announcement expands research infrastructure, without establishing a new computational advantage.

    IBM ·

  4. SolarEdge puts 800-volt AI power to the test.

    SolarEdge says its medium-voltage-to-800-volt DC converter is running under load in its labs. It also published a protection framework with NVIDIA. Full-system validation continues, and the AI data-center products are not yet generally available.

    SolarEdge announcement ·

Explore by topic

Pick a frontier.

Seven fields. A clear place to begin.

The Vastkind Briefing

A little
perspective.

Technology and science, with the evidence and consequences explained.

Check your inbox.

Click the confirmation link in your email to complete your subscription. If it hasn’t arrived, check your spam folder.

Find something to read

Occasional editions. Free to subscribe.
Unsubscribe anytime.

Explore Vastkind

Find your
frontier.

Subscribe

Stay curious. Stay informed.

For another moment

Your reading list

Saved on this device. No account needed.

Something catch your eye? Use the bookmark beside an article to keep it here.